Les Ulis, France

Romain Luc Marie Gosmini

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 87(Granted Patents)


Location History:

  • Les Ulls, FR (2008)
  • Les Ulis, FR (2005 - 2017)

Company Filing History:


Years Active: 2005-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Romain Luc Marie Gosmini: Innovator in Pharmaceutical Chemistry

Introduction

Romain Luc Marie Gosmini is a notable inventor based in Les Ulis, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of benzodiazepine compounds. With a total of 10 patents to his name, Gosmini's work has had a considerable impact on therapeutic applications.

Latest Patents

Among his latest patents, Gosmini has developed benzodiazepine bromodomain inhibitors. These include benzodiazepine compounds of formula (I) and their salts, as well as pharmaceutical compositions containing such compounds. His innovative work focuses on the therapeutic uses of these compounds, showcasing his expertise in medicinal chemistry.

Career Highlights

Throughout his career, Romain Luc Marie Gosmini has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with GlaxoSmithKline LLC and SmithKline Beecham Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Gosmini has collaborated with several esteemed professionals in his field, including Olivier Mirguet and Emmanuel Hubert Demont. These partnerships have facilitated the exchange of ideas and fostered innovation in the development of new therapeutic agents.

Conclusion

Romain Luc Marie Gosmini stands out as a significant figure in pharmaceutical innovation. His contributions through patents and collaborations highlight his commitment to advancing medical science. His work continues to influence the development of effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…